Literature DB >> 28122703

Novel psychoactive substances: identifying and managing acute and chronic harmful use.

Derek K Tracy1,2, David M Wood3,4, David Baumeister5.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28122703     DOI： 10.1136/bmj.i6814

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

Review 1.  Naltrexone efficacy in treating alcohol-use disorder in individuals with comorbid psychosis: a systematic review.

Authors:  Martyna Sawicka; Derek K Tracy
Journal:  Ther Adv Psychopharmacol       Date:  2017-05-24

2.  The challenge of the novel psychoactive substances: How have we responded and what are the implications of this response?

Authors:  David M Wood; Paul I Dargan
Journal:  Br J Clin Pharmacol       Date:  2020-03-06       Impact factor: 4.335

3.  Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of novel psychoactive substances.

Authors:  Elena Deligianni; Omari J Daniel; John M Corkery; Fabrizio Schifano; Lisa A Lione
Journal:  Br J Clin Pharmacol       Date:  2020-01-09       Impact factor: 4.335

4.  Exploration of the Use of New Psychoactive Substances by Individuals in Treatment for Substance Misuse in the UK.

Authors:  Rosalind Gittins; Amira Guirguis; Fabrizio Schifano; Ian Maidment
Journal:  Brain Sci       Date:  2018-03-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.